Literature DB >> 32341536

Comparison of automated and expert human grading of diabetic retinopathy using smartphone-based retinal photography.

Tyson N Kim1,2, Michael T Aaberg3, Patrick Li3, Jose R Davila3, Malavika Bhaskaranand4, Sandeep Bhat4, Chaithanya Ramachandra4, Kaushal Solanki4, Frankie Myers5, Clay Reber5, Rohan Jalalizadeh3, Todd P Margolis6, Daniel Fletcher5, Yannis M Paulus7,8.   

Abstract

PURPOSE: The aim of this study is to investigate the efficacy of a mobile platform that combines smartphone-based retinal imaging with automated grading for determining the presence of referral-warranted diabetic retinopathy (RWDR).
METHODS: A smartphone-based camera (RetinaScope) was used by non-ophthalmic personnel to image the retina of patients with diabetes. Images were analyzed with the Eyenuk EyeArt® system, which generated referral recommendations based on presence of diabetic retinopathy (DR) and/or markers for clinically significant macular oedema. Images were independently evaluated by two masked readers and categorized as refer/no refer. The accuracies of the graders and automated interpretation were determined by comparing results to gold standard clinical diagnoses.
RESULTS: A total of 119 eyes from 69 patients were included. RWDR was present in 88 eyes (73.9%) and in 54 patients (78.3%). At the patient-level, automated interpretation had a sensitivity of 87.0% and specificity of 78.6%; grader 1 had a sensitivity of 96.3% and specificity of 42.9%; grader 2 had a sensitivity of 92.5% and specificity of 50.0%. At the eye-level, automated interpretation had a sensitivity of 77.8% and specificity of 71.5%; grader 1 had a sensitivity of 94.0% and specificity of 52.2%; grader 2 had a sensitivity of 89.5% and specificity of 66.9%. DISCUSSION: Retinal photography with RetinaScope combined with automated interpretation by EyeArt achieved a lower sensitivity but higher specificity than trained expert graders. Feasibility testing was performed using non-ophthalmic personnel in a retina clinic with high disease burden. Additional studies are needed to assess efficacy of screening diabetic patients from general population.

Entities:  

Mesh:

Year:  2020        PMID: 32341536      PMCID: PMC7852658          DOI: 10.1038/s41433-020-0849-5

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  52 in total

Review 1.  Diabetic retinopathy.

Authors:  David A Antonetti; Ronald Klein; Thomas W Gardner
Journal:  N Engl J Med       Date:  2012-03-29       Impact factor: 91.245

2.  How effective are treatments for diabetic retinopathy?

Authors:  F L Ferris
Journal:  JAMA       Date:  1993-03-10       Impact factor: 56.272

3.  Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.

Authors:  David S Boyer; Young Hee Yoon; Rubens Belfort; Francesco Bandello; Raj K Maturi; Albert J Augustin; Xiao-Yan Li; Harry Cui; Yehia Hashad; Scott M Whitcup
Journal:  Ophthalmology       Date:  2014-06-04       Impact factor: 12.079

4.  Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.

Authors:  Sophia Y Wang; Chris A Andrews; William H Herman; Thomas W Gardner; Joshua D Stein
Journal:  Ophthalmology       Date:  2016-11-30       Impact factor: 12.079

Review 5.  A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors:  P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

Review 6.  Vascular Endothelial Growth Factor and Diabetic Retinal Disease.

Authors:  Radwan S Ajlan; Paolo S Silva; Jennifer K Sun
Journal:  Semin Ophthalmol       Date:  2016       Impact factor: 1.975

Review 7.  Management of proliferative diabetic retinopathy.

Authors:  Kaan Gündüz; Sophie J Bakri
Journal:  Compr Ophthalmol Update       Date:  2007 Sep-Oct

8.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.

Authors:  John M Lachin; Neil H White; Dean P Hainsworth; Wanjie Sun; Patricia A Cleary; David M Nathan
Journal:  Diabetes       Date:  2014-09-09       Impact factor: 9.461

10.  Association between socioeconomic status and metabolic control and diabetes complications: a cross-sectional nationwide study in Chinese adults with type 2 diabetes mellitus.

Authors:  Xiaoming Tao; Jihu Li; Xiaolin Zhu; Bin Zhao; Jiao Sun; Linong Ji; Dayi Hu; Changyu Pan; Yuxin Huang; Suyuan Jiang; Qiang Feng; Cuiping Jiang
Journal:  Cardiovasc Diabetol       Date:  2016-04-05       Impact factor: 9.951

View more
  3 in total

1.  A Comparison of Artificial Intelligence and Human Diabetic Retinal Image Interpretation in an Urban Health System.

Authors:  Nikita Mokhashi; Julia Grachevskaya; Lorrie Cheng; Daohai Yu; Xiaoning Lu; Yi Zhang; Jeffrey D Henderer
Journal:  J Diabetes Sci Technol       Date:  2021-03-10

2.  Optimized hybrid machine learning approach for smartphone based diabetic retinopathy detection.

Authors:  Shubhi Gupta; Sanjeev Thakur; Ashutosh Gupta
Journal:  Multimed Tools Appl       Date:  2022-02-25       Impact factor: 2.577

3.  Deep learning-based automated detection for diabetic retinopathy and diabetic macular oedema in retinal fundus photographs.

Authors:  Feng Li; Yuguang Wang; Tianyi Xu; Lin Dong; Lei Yan; Minshan Jiang; Xuedian Zhang; Hong Jiang; Zhizheng Wu; Haidong Zou
Journal:  Eye (Lond)       Date:  2021-07-01       Impact factor: 4.456

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.